Tirzepatide is an injectable peptide medication that acts on two key hormones involved in metabolism: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). By mimicking and amplifying the effects of these hormones, it helps regulate blood sugar, reduce appetite, slow gastric emptying, and promote a feeling of fullness.